Souhaitez-vous accéder aux communiqués récents ?

Basel, June 1, 2018 - Novartis AG ("Novartis") today announced the completion of the divestment to GlaxoSmithKline PLC ("GSK") of its 36.5 percent stake in a consumer healthcare joint venture (JV)...

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.         KEY...

Sandoz is seeking approval of proposed biosimilar adalimumab for use in all reference medicine indications including those in rheumatology, gastroenterology and dermatology Positive CHMP opinion...

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.         KEY...

If approved, Aimovig®(erenumab) is expected to be the first and only available therapy designed specifically for migraine prevention in the EU Positive opinion based on robust data package...

GEIGER COUNTER LIMITED            Date of Announcement: 01/06/2018               Net Asset Values per share as at:31/05/2018              The unaudited net asset value (NAV) of the company is noted...

Reykjavík, miðvikudagur, 1. júní, 2018 -- Nasdaq (Nasdaq:NDAQ) gefur út viðskiptayfirlit mánaðarlega fyrir kauphallir sínar á Norðurlöndunum og í Eystrasaltsríkjunum.  Helstu atriði úr...

LONDON, June 01, 2018 (GLOBE NEWSWIRE) -- Horizonte Minerals Plc, (AIM:HZM) (TSX:HZM) ('Horizonte' or 'the Company') the nickel development company focused in Brazil, has on the basis of the...

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Downing ONE VCT plcLEI:...

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Rathbone Brothers Plc ("the...